BioMedomics, Inc. — Form D/A
BioMedomics, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D amendment with the SEC on 2014-01-06. The offering totals $3.0M, of which $690K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-01-06
- Form: D/A
- Accession: 0001140361-14-000844
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $690K
- Remaining: $2.3M
- Investors: 13
- Date of first sale: 2013-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209350
Issuer
- Name: BioMedomics, Inc.
- CIK: 0001595601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 6 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 919-883-5542
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| J. ROBERT TYLER, III | Executive Officer | RALEIGH, NC |
| TOM ROBERG | Director | RESEARCH TRIANGLE PARK, NC |
| LIN WU | Director | RESEARCH TRIANGLE PARK, NC |
| FRANK WANG | Director | RESEARCH TRIANGLE PARK, NC |
| FRANK WANG | Executive Officer | RESEARCH TRIANGLE PARK, NC |
| CAM PATTERSON | Director | RESEARCH TRIANGLE PARK, NC |
| PHILLIP S WISE | Executive Officer | DURHAM, NC |
Other filings by this issuer (3)
More